Lipoprotein(a)

Lp(a) is built from an LDL-like particle carrying apolipoprotein B plus apolipoprotein(a), a second protein whose size varies because the LPA gene contains a variable number of repeated segments. Smaller apo(a) forms are often associated with higher circulating Lp(a) concentrations. This particle also carries oxidized phospholipids, which may help explain its links to plaque formation, inflammation, and calcific aortic valve disease.

The number that hides outside the usual cholesterol panel

A routine lipid panel can tell you your LDL, HDL, and triglycerides, then completely miss lipoprotein(a). That is the trap. Many people first hear about Lp(a) only after a heart attack at a young age, a parent’s unexplained early stroke, or a doctor notices a family pattern that ordinary cholesterol numbers do not fully explain.

The surprise is that Lp(a) is not just “more cholesterol.” It is an LDL particle with an extra protein tail attached. Picture a delivery truck with a strip of Velcro dragging behind it: the truck already carries cholesterol, but the Velcro makes it more likely to snag onto rough spots in the artery wall and contribute to plaque, inflammation, and clotting risk. That extra tail is why Lp(a) behaves differently from ordinary LDL.

Why two people with the same LDL can have different risk

Most of your Lp(a) level is set by your genes, and it stays fairly stable over life unless you are dealing with a major illness or a special treatment situation. That is why major groups now support measuring it at least once in adulthood, rather than waiting for repeated routine cholesterol tests to reveal the problem.

This also explains an annoying lab detail: nmol/L and mg/dL are not interchangeable by a simple calculator. Nmols count particles. Mg/dL measures mass. Because Lp(a) particles vary in size between people, a fixed conversion can mislead. In plain English: two people can have the “same weight” of Lp(a) but a different number of particles.

A commonly used interpretation is:

• Below 75 nmol/L (about below 30 mg/dL): lower range
• 75 to 125 nmol/L (about 30 to 50 mg/dL): gray zone
• 125 nmol/L or higher (about 50 mg/dL or higher): high, and considered a risk-enhancing level in major guidelines

Some labs and older references use slightly different cutoffs, which is why your report may not match someone else’s screenshot online.

What a high result means, and what it does not mean

A high Lp(a) does not mean symptoms are about to start. In fact, high lipoprotein(a) symptoms are usually no symptoms at all; it is a risk marker, not a feeling. It also does not give a precise countdown or a fixed “life expectancy with high lipoprotein(a).” Risk depends on the rest of the picture: LDL cholesterol, blood pressure, diabetes, smoking, kidney disease, family history, and whether plaque is already present.

Can you lower your lipoprotein A? Not much with diet, exercise, or supplements alone. Lifestyle still matters enormously, but mostly because it lowers the other parts of risk around Lp(a), not because it reliably drags Lp(a) down itself. PCSK9 inhibitors can lower it modestly, and newer Lp(a)-targeted drugs are being studied, but as of now the practical move is usually to treat the surrounding risk factors aggressively.

One decision that matters today

If you have a personal or family history of early cardiovascular disease, ask for a lipoprotein(a) test once, even if your usual cholesterol numbers seem acceptable. For this biomarker, finding out you are high often changes how seriously you and your clinician approach LDL lowering and family screening.

If you are someone who keeps repeating a standard cholesterol panel every year but has never had Lp(a) measured, the failure mode is assuming “normal cholesterol” means inherited risk has been checked. It has not. For this marker, one well-chosen test can matter more than many repeated panels that never included it.